Clinical Trial Update: BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal [NA]

View source ↗

Summary

The BOLSTER clinical trial (NCT03367247) sponsored by Dana-Farber Cancer Institute is completed, covering gynecologic and gastrointestinal cancers, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Gynecologic Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Gynecologic Cancer, Gastrointestinal Cancer | NA | Status: COMPLETED | Results posted: 2023-08-15